研究者業績

清水 啓介

シミズ ケイスケ  (Keisuke Shimizu)

基本情報

所属
千葉大学 未来医療教育研究機構 特任助教

研究者番号
20937130
J-GLOBAL ID
202201009997261184
researchmap会員ID
R000032328

研究キーワード

 1

論文

 14
  • Hiroto Chikubu, Kazuhide Inage, Sumihisa Orita, Yasuhiro Shiga, Masahiro Inoue, Keisuke Shimizu, Miyako Suzuki-Narita, Ikuko Tajiri, Michiaki Mukai, Natsuko Nozaki-Taguchi, Seiji Ohtori
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2024年9月22日  査読有り
    Co-administration of mirogabalin besylate and nonsteroidal anti-inflammatory drugs is effective for neuropathic pain; however, mechanism of its action remains unknown. We aimed to evaluate the mechanism of this synergistic effect of the concomitant administration for neuropathic pain using chronic constriction injury model rats. Fifty male Wister rats of 7-week-old were used. Right sciatic nerve ligation was performed in 40 rats and they were sub-divided into four groups: vehicle, mirogabalin, diclofenac sodium and co-administration of them. Ten rats underwent sham surgery. Fluorogold was attached to sciatic nerve during surgery. Von Frey filament and weight bearing tests were performed on postoperative Day 6 as behavioral assessments and drug was administrated intraperitoneally. Half rats in each group underwent behavioral assessment and perfusion fixation using 4% paraformaldehyde on postoperative Day 7 and remaining on postoperative Day 14. Subsequently, dorsal root ganglion at L4 to L6 was collected and examined immunohistochemistry for calcitonin gene-related peptide, and their immunoreactivity in fluorogold-labeled neurons was measured. Spinal cord at lumbar swelling was resected, immunostained for ionized-calcium-binding adapter molecule-1 and glial fibrillary acidic protein, and immunoreactive neurons in dorsal horn of spinal cords were calculated as the occupancy of them. Mirogabalin suppresses the neuropeptide-release from presynaptic afferent neuron directly and it resulted in suppressing glia cells activation. Diclofenac sodium inhibits cyclooxygenase-2 and prostaglandin production, related to allodynia. These effects of mirogabalin and diclofenac sodium, respectively, inhibited glia cells strongly, which is presumed to be one of the mechanisms for the effectiveness of their co-administration for neuropathic pain.
  • Masahiro Inoue, Shiro Sugiura, Taiki Takeda, Takato Hoshino, Keisuke Shimizu, Kazuhide Inage, Yasuhiro Shiga, Kohei Okuyama, Seiji Ohtori, Sumihisa Orita
    Cureus 2024年8月26日  査読有り
  • Yawara Eguchi, Yasuchika Aoki, Masaomi Yamashita, Kazuki Fujimoto, Takashi Sato, Koki Abe, Masashi Sato, Hajime Yamanaka, Toru Toyoguchi, Keisuke Shimizu, Sumihisa Orita, Kazuhide Inage, Yasuhiro Shiga, Seiji Ohtori
    Pain and Therapy 2023年1月16日  査読有り
  • Keisuke Shimizu, Kazuhide Inage, Mitsuo Morita, Ryota Kuroiwa, Hiroto Chikubu, Tadashi Hasegawa, Natsuko Nozaki-Taguchi, Sumihisa Orita, Yasuhiro Shiga, Yawara Eguchi, Kazuhiko Takabatake, Seiji Ohtori
    Scientific Reports 12(1) 14532-14532 2022年8月25日  査読有り筆頭著者責任著者
    Abstract The lifetime prevalence of low back pain is 83%. Since there is a lack of evidence for therapeutic effect by cognitive behavioral therapy (CBT) or physical therapy (PT), it is necessary to develop objective physiological indexes and effective treatments. We conducted a prospective longitudinal study to evaluate the treatment effects of CBT, PT, and neurofeedback training (NFT) during alpha wave NFT. The early-chronic cases within 1 year and late-chronic cases over 1 year after the diagnosis of chronic low back pain were classified into six groups: Controls, CBTs, PTs, NFTs, CBT-NFTs, PT-NFTs. We evaluated the difference in EEG, psychosocial factors, scores of low back pain before/after the intervention. Therapeutic effect was clearly more effective in the early-chronic cases. We found that the intensity of alpha waves increased significantly after therapeutic intervention in the NFT groups, but did not have the main effect of reducing low back pain; the interaction between CBT and NFT reduced low back pain. Factors that enhance therapeutic effect are early intervention, increased alpha waves, and self-efficacy due to parallel implementation of CBT/PT and NFT. A treatment protocol in which alpha wave neurofeedback training is subsidiarily used with CBT or PT should be developed in the future.
  • Keisuke Shimizu, Kazuhide Inage, Sumihisa Orita, Yawara Eguchi, Yasuhiro Shiga, Masao Koda, Yasuchika Aoki, Toshiaki Kotani, Tsutomu Akazawa, Takeo Furuya, Junichi Nakamura, Hiroshi Takahashi, Miyako Suzuki-Narita, Satoshi Maki, Shigeo Hagiwara, Masahiro Inoue, Masaki Norimoto, Hideyuki Kinoshita, Takashi Sato, Masashi Sato, Keigo Enomoto, Hiromitsu Takaoka, Norichika Mizuki, Takashi Hozumi, Ryuto Tsuchiya, Geundong Kim, Takuma Otagiri, Tomohito Mukaihata, Takahisa Hishiya, Seiji Ohtori
    Scientific Reports 11(1) 2021年12月  査読有り筆頭著者責任著者
    Abstract This study examined the factors that inhibit the therapeutic effects of cognitive behavioral therapy (CBT) and clarify the adaptation judgment criteria of CBT. We included patients with chronic low back pain and allocated them to the adaptation (with visual analog scale [VAS] improvement) or non-adaptation group (without VAS improvement). The patients were analyzed using various psychological tests. CBT improved depressive symptoms and catastrophic thinking; however, they were not correlated with the VAS and did not directly affect low back pain improvement. The non-adaptation group showed an unexplainable/vague sense of anxiety; an excessive focus on searching for pain; a strong intimacy desire; a strong tendency of medical dependency; and fantasy or distortion of the actual experience, especially self-image. Moreover, the patients showed a low ability to objectively express or attribute meaning to pain due to poor language skills, attention-deficit hyperactivity disorder, and emotional value judgment. Individuals with the aforementioned characteristics of pre-CBT psychological tests should select a different treatment approach given the high poor-adaption possibility. Even patients with depressive or anxious symptoms are not necessarily adaptable for CBT. Therefore, pre-CBT tests for treatment suitability are necessary. Future studies should establish a protocol for psychotherapy suitable for the non-adaptation group.

MISC

 22

書籍等出版物

 2

共同研究・競争的資金等の研究課題

 1